Back
  1. Home
  3. Detailed Reference
Download
Paper published in a journal (Scientific congresses and symposiums)
Efficacy and safety of CT-P41, a proposed denosumab biosimilar, compared to reference denosumab (prolia) in postmenopausal women with osteoporosis
Reginster, Jean-Yves; CZERWINSKI, E.; STRZELECKA, A. et al.
2024 • In Aging Clinical and Experimental Research, 36 (S1)
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/333721
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
WCO-IOF-ESCEO 2024 abstracts publiés Aging Clin Exp Res.pdf
Author postprint (44.06 MB)
Download

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
Public health, health care sciences & services
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique ; KSU - King Saud University > Departement of Biochemistry > College of Science
CZERWINSKI, E.
STRZELECKA, A.
SZYMANOWSKI, K.
POSTOL, S.
PODER, A.
SUPRONIK, J.
WILK, K.
BOROWY, P.
BUDLEWSKI, T.
JANOWSKA-MAUS, M.
KWIATEK, J.
KIM, S.H.
SUH, J.H.
HAN, N.R.
KIM, N.H.
BAE, S.H.
SILVERMAN, S.L.
More authors (8 more) Less
Language :
English
Title :
Efficacy and safety of CT-P41, a proposed denosumab biosimilar, compared to reference denosumab (prolia) in postmenopausal women with osteoporosis
Publication date :
2024
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletazl Diseases
Event organizer :
IOF-ESCEO
Event place :
London, United Kingdom
Event date :
11-14 April 2024
Audience :
International
Journal title :
Aging Clinical and Experimental Research
ISSN :
1594-0667
eISSN :
1720-8319
Publisher :
Springer, Germany
Volume :
36
Issue :
S1
Peer review/Selection committee :
Peer Reviewed verified by ORBi
Available on ORBi :
since 01 July 2025

Statistics

Number of views
14 (1 by ULiège)
Number of downloads
14 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi